NCT02452216View on ClinicalTrials.gov

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 10, 2015

Primary Completion Date

January 12, 2017

Study Completion Date

January 12, 2017

Conditions
Brain InjuryCentral Nervous System Degenerative DisorderCentral Nervous System Infectious DisorderCentral Nervous System Vascular MalformationHemorrhagic Cerebrovascular AccidentIschemic Cerebrovascular AccidentPrimary Brain NeoplasmBrain CancerBrain Tumors
Interventions
DRUG

Ferumoxytol

Undergo ferumoxytol-enhanced MRI

OTHER

Tissue Analysis

Correlative analysis for macrophage detection and quantification. This applies for all patients in the experimental arm who undergo ferumoxytol infusion.

PROCEDURE

Magnetic Resonance Imaging

All subjects in the experimental arm who undergo ferumoxytol infusion will subsequently have MRI.

Trial Locations (1)

94305

Stanford University Hospitals and Clinics, Stanford

All Listed Sponsors
lead

Michael Iv

OTHER

NCT02452216 - Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS | Biotech Hunter | Biotech Hunter